N/A N=172 Randomized Double-blind Treatment

Treatment of PTSD in Residents of Battered Women's Shelters

PTSD

Bottom Line

View on ClinicalTrials.gov: NCT02398227 ↗

Enrolled (actual)

172

Serious AEs

65.1%

Results posted

Aug 2018

Primary outcome: Primary: Clinician Administered PTSD Scale (CAPS) — 48.08; 52.39; 31.75; 34.43 units on a scale — p=.968

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: HOPE (Behavioral); PCT (Behavioral)
Age: Pediatric, Adult, Older Adult
Sex: Female
Sponsor: The University of Akron
Primary completion: Jun 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Clinician Administered PTSD Scale (CAPS)	48.08; 52.39; 31.75; 34.43; 29.36; 32.63	.968
PRIMARY Severity of Violence Against Women Scale (SVAWS)	7.81; 13.89; 3.47; 1.10; 3.42; 2.73	.560

Summary

This is a study comparing a new treatment (HOPE) to supportive therapy in the treatment of PTSD in residents of battered women's shelters.

Eligibility Criteria

Inclusion Criteria

must be resident in one of the 6 participating shelters,
IPV in month prior to shelter,
PTSD

Exclusion Criteria

substance dependence in last 3 months,
change in meds in last month,
Bipolar d/o,
psychosis,
active suicidality

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02398227). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.